Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

53,000 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Proteomic profiling of single extracellular vesicles reveals colocalization of SARS-CoV-2 with a CD81/integrin-rich EV subpopulation in sputum from COVID-19 severe patients.
Sun R, Cai Y, Zhou Y, Bai G, Zhu A, Kong P, Sun J, Li Y, Liu Y, Liao W, Liu J, Cui N, Xiang J, Li B, Zhao J, Wu D, Ran P. Sun R, et al. Among authors: zhao j. Front Immunol. 2023 May 12;14:1052141. doi: 10.3389/fimmu.2023.1052141. eCollection 2023. Front Immunol. 2023. PMID: 37251406 Free PMC article.
Identification of a broad sarbecovirus neutralizing antibody targeting a conserved epitope on the receptor-binding domain.
Wang Y, Zhang Z, Yang M, Xiong X, Yan Q, Cao L, Wei P, Zhang Y, Zhang L, Lv K, Chen J, Liu X, Zhao X, Xiao J, Zhang S, Zhu A, Gan M, Zhang J, Cai R, Zhuo J, Zhang Y, Rao H, Qu B, Zhang Y, Chen L, Dai J, Cheng L, Hu Q, Chen Y, Lv H, So RTY, Peiris M, Zhao J, Liu X, Mok CKP, Wang X, Zhao J. Wang Y, et al. Among authors: zhao j, zhao x. Cell Rep. 2024 Jan 23;43(1):113653. doi: 10.1016/j.celrep.2023.113653. Epub 2024 Jan 3. Cell Rep. 2024. PMID: 38175758 Free article.
Characterization of humoral immune responses against SARS-CoV-2 accessory proteins in infected patients and mouse model.
Li Y, Tang Y, Wang X, Zhu A, Liu D, He Y, Guo H, Zheng J, Liu X, Chi F, Wang Y, Zhuang Z, Zhang Z, Liu D, Chen Z, Li F, Ran W, Yu K, Wang D, Wen L, Zhuo J, Zhang Y, Xi Y, Zhao J, Zhao J, Sun J. Li Y, et al. Among authors: zhao j. Virol Sin. 2024 Apr 25:S1995-820X(24)00061-0. doi: 10.1016/j.virs.2024.04.005. Online ahead of print. Virol Sin. 2024. PMID: 38677713 Free article.
Safety, tolerability, and immunogenicity of a CpG/Alum adjuvanted SARS-CoV-2 recombinant protein vaccine (ZR202-CoV) in healthy adults: Preliminary report of a phase 1, randomized, double-blind, placebo-controlled, dose-escalation trial.
Feng GW, Wang ZF, He P, Lan QY, Ni L, Yang YZ, Wang CF, Cui TT, Huang LL, Yan YQ, Jiang ZW, Yang Q, Yu BW, Han X, Chen JJ, Yang SY, Yuan L, Zhou LY, Liu G, Li K, Huang Z, Zhao JC, Hu ZY, Xie ZQ. Feng GW, et al. Hum Vaccin Immunother. 2023 Aug;19(2):2262635. doi: 10.1080/21645515.2023.2262635. Epub 2023 Oct 26. Hum Vaccin Immunother. 2023. PMID: 37881130 Free PMC article. Clinical Trial.
53,000 results
You have reached the last available page of results. Please see the User Guide for more information.